Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-024588
Filing Date
2021-06-17
Accepted
2021-06-17 21:32:45
Documents
2
Period of Report
2021-06-17

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4492
2 EX-24 DOCUMENT attachment1.htm EX-24 4051
  Complete submission text file 0000899243-21-024588.txt   9984
Mailing Address C/O CALITHERA BIOSCIENCES, INC. 343 OYSTER POINT BLVD., SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address
Molineaux Susan (Reporting) CIK: 0001553389 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40499 | Film No.: 211026912

Mailing Address 128 SPRING STREET BUILDING A, SUITE 510 LEXINGTON MA 02421
Business Address 128 SPRING STREET BUILDING A, SUITE 510 LEXINGTON MA 02421 857-285-4140
Cyteir Therapeutics, Inc. (Issuer) CIK: 0001662244 (see all company filings)

EIN.: 455429901 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations